Form4insider filings, from the source

SEC Form 4 · accession 0001562180-18-004188

G1 Therapeutics, Inc. · GTHX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Seth Rudnick
Director
Period of report
Oct 4, 2018
Accepted (ET)
Oct 5, 2018 · 6:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001560241

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockOct 4, 2018M10,000$0.39A10,000D
Common StockF2Oct 4, 2018S8,020$49.6545D1,980D
Common StockF3Oct 4, 2018S1,980$49.9906D0D
Common StockF4holding———58,282ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Options (Right to Buy)F5$0.39Oct 4, 2018M10,000D—Jan 21, 2024Common Stock10,00010,607D

Explanation of responses